Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.9 |
mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |